Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies episode artwork

EPISODE · Dec 14, 2023 · 18 MIN

Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies

from Keeping Current CME

Did you know that different types of drug resistance to antibody-drug conjugates (ADCs) can develop at different sites in the same patient? How may this impact ADC sequencing? Credit available for this activity expires: 12/13/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999152?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published Dec 14, 2023

Embed this episode

NOW PLAYING

Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies

0:00 18:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 18 minutes long.

When was this Keeping Current CME episode published?

This episode was published on December 14, 2023.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!